CRISPR-based therapeutics hold potential to combat AMR and cure chronic viral infections: GlobalData
GlobalData report explores clinical progress, market trends, and regulatory developments shaping CRISPR-based therapies for…
Author
Goa to introduce pricing policy for innovative lifesaving therapies
State to be reportedly first in India to implement outcome-linked pricing for advanced treatments, beginning with lung cancer
Government of India to host Bharat NutraVerse Expo 2025
Government of India, through SHEFEXIL, to bring global nutraceutical leaders together in New Delhi from 4–6 September 2025 to…
Greenspace Herbs unveils Quantum Ayurveda technology platform
The business has mapped 25,000 bioactive signatures and is currently working on 150,000 more
Lilly launches Mounjaro KwikPen (tirzepatide) in India
The pen will be available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, allowing healthcare…
Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA
The acquisition will be funded through the IPO proceeds raised by Senores. This is in line with the Objects of the IPO stated in…
Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20…
Rivaroxaban Tablets USP will be manufactured at the company’s facility located in Goa
Cohance Lifesciences announces ₹230 mn investment and progress on cGMP Oligonucleotide facility at…
Integrated with a pilot plant for early-stage synthesis and for non-GMP scale-up, the facility will add fit-for-purpose GMP…
Panel Discussion: Building a high-value pharma destination: Making Chandigarh–Baddi investor-ready
Chandigarh Pharma Summit 2025 | 6th August 2025 | Taj Chandigarh
Mr Rajan Ramalingam, Senior Partner, InACE Pharma Consulting
Chandigarh Pharma Summit 2025 | 6th August 2025 | Taj Chandigarh